Drug guidance
Guselkumab, ixekizumab and secukinumab for treating chronic plaque psoriasis
Condition
Blood and Immune System
Skin
31 August 2022
Published on 18 Jan 2021
Last Updated on 31 Aug 2022
Guselkumab, ixekizumab and secukinumab for treating chronic plaque psoriasis Guidance is outdated and has been withdrawn on 31 August 2022. The Plain English Summary (PES) has been updated on 31 August 2022.